These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26104082)

  • 1. Intraindividual Crossover Comparison of Gadoxetic Acid Dose for Liver MRI in Normal Volunteers.
    Motosugi U; Bannas P; Hernando D; Salmani Rahimi M; Holmes JH; Reeder SB
    Magn Reson Med Sci; 2016; 15(1):60-72. PubMed ID: 26104082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid.
    Frydrychowicz A; Nagle SK; D'Souza SL; Vigen KK; Reeder SB
    J Magn Reson Imaging; 2011 Sep; 34(3):585-94. PubMed ID: 21751288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined gadoxetic acid and gadofosveset enhanced liver MRI: A feasibility and parameter optimization study.
    Bannas P; Motosugi U; Hernando D; Rahimi MS; Holmes JH; Reeder SB
    Magn Reson Med; 2016 Jan; 75(1):318-28. PubMed ID: 25648403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High spatial resolution, respiratory-gated, t1-weighted magnetic resonance imaging of the liver and the biliary tract during the hepatobiliary phase of gadoxetic Acid-enhanced magnetic resonance imaging.
    Lee ES; Lee JM; Yu MH; Shin CI; Woo HS; Joo I; Stemmer A; Han JK; Choi BI
    J Comput Assist Tomogr; 2014; 38(3):360-6. PubMed ID: 24681858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of 5-minute delayed transition phase imaging with 30° flip angle in gadoxetic acid-enhanced 3D gradient-echo MRI of liver, compared with 20-minute delayed hepatocyte phase MRI with standard 10° flip angle.
    Cho ES; Yu JS; Park AY; Woo S; Kim JH; Chung JJ
    AJR Am J Roentgenol; 2015 Jan; 204(1):69-75. PubMed ID: 25539239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined gadoxetic acid and gadobenate dimeglumine enhanced liver MRI: a parameter optimization study.
    Knobloch G; Colgan T; Wang X; Woo KM; Schubert T; Reeder SB
    Abdom Radiol (NY); 2020 Jan; 45(1):220-231. PubMed ID: 31606763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA.
    Zech CJ; Vos B; Nordell A; Urich M; Blomqvist L; Breuer J; Reiser MF; Weinmann HJ
    Invest Radiol; 2009 Jun; 44(6):305-10. PubMed ID: 19462484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol.
    Kühn JP; Hegenscheid K; Siegmund W; Froehlich CP; Hosten N; Puls R
    AJR Am J Roentgenol; 2009 Nov; 193(5):1318-23. PubMed ID: 19843748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two different injection rates of gadoxetic acid for arterial phase MRI of the liver.
    Chung SH; Kim MJ; Choi JY; Hong HS
    J Magn Reson Imaging; 2010 Feb; 31(2):365-72. PubMed ID: 20099350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial phase on gadoxetic acid-enhanced liver MR imaging: a randomized comparison of 0.5 mL/s and 1 mL/s injection rates.
    Kim SM; Heo SH; Kim JW; Lim HS; Shin SS; Jeong YY; Kang HK
    Korean J Radiol; 2014; 15(5):605-12. PubMed ID: 25246821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fat-suppressed, three-dimensional T1-weighted imaging using high-acceleration parallel acquisition and a dual-echo Dixon technique for gadoxetic acid-enhanced liver MRI at 3 T.
    Yoon JH; Lee JM; Yu MH; Kim EJ; Han JK; Choi BI
    Acta Radiol; 2015 Dec; 56(12):1454-62. PubMed ID: 25480475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrahigh-field imaging of the biliary tract at 7 T: initial results of gadoxetic acid-enhanced magnetic resonance cholangiography.
    Fischer A; Kraff O; Orzada S; Nensa F; Schäfer LC; Ladd ME; Umutlu L; Lauenstein TC
    Invest Radiol; 2014 May; 49(5):346-53. PubMed ID: 24141740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
    Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
    Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thin-slice Free-breathing Pseudo-golden-angle Radial Stack-of-stars with Gating and Tracking T
    Kajita K; Goshima S; Noda Y; Kawada H; Kawai N; Okuaki T; Honda M; Matsuo M
    Magn Reson Med Sci; 2019 Jan; 18(1):4-11. PubMed ID: 29526882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.
    Kim KA; Kim MJ; Park MS; Lim JS; Choi JY; Hong HS; Kim KW
    Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol.
    Zizka J; Klzo L; Ferda J; Mrklovský M; Bukac J
    Eur J Radiol; 2007 May; 62(2):186-91. PubMed ID: 17367974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement effects of hepatic dynamic MR imaging at 3.0 T and 1.5 T using gadoxetic acid in a phantom study: comparison with gadopentetate dimeglumine.
    Morita K; Namimoto T; Awai K; Komi M; Hashida M; Tsuji T; Hirai T; Yamashita Y
    Magn Reson Med; 2011 Jul; 66(1):213-8. PubMed ID: 21254212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase.
    Torrisi C; Picone D; Cabibbo G; Matranga D; Midiri M; Brancatelli G
    Eur J Radiol; 2018 Oct; 107():39-45. PubMed ID: 30292271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.